A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19
Clinical trial NCT04810637 · UNKNOWN
Trial details
- NCT number
- NCT04810637
- Sponsor
- PT Kalbe Genexine Biologics
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-01
- Primary completion
- 2021-06-01
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.